Nemolizumab (CIM331) is a humanized monoclonal antibody targeting the human interleukin-31 receptor A, inhibiting IL-31 binding and subsequent signal transduction. It is useful for studying atopic dermatitis with pruritus.
Purity:
95.00%
CAS Number:
[1476039-58-3]
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted